Clinical Characteristics of HIV-Infected Patients with Venous Thromboembolism and Different CD4⁺ T Lymphocyte Levels

References

• Benjamin EJ, Virani SS, Callaway CW. Heart disease and stroke statistics-2018 update: a report from the American Heart Association. Circulation. 2018;137:e67–e492. doi:10.1161/CIR.0000000000000558
   PubMed Web of Science ®Google Scholar
• Ghosn J, Taiwo B, Seedat S, Autran B, Katlama C. HIV. Lancet. 2018;392(10148):685–697. doi:10.1016/S0140-6736(18)31311-4
   PubMed Web of Science ®Google Scholar
• Palella FJ, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med. 1998;338:853–860. doi:10.1056/NEJM199803263381301
   PubMed Web of Science ®Google Scholar
• Murphy EL, Collier AC, Kalish LA, et al. Highly active antiretroviral therapy decreases mortality and morbidity in patients with advanced HIV disease. Ann Intern Med. 2001;135(1):17–26. doi:10.7326/0003-4819-135-1-200107030-00005
   PubMed Web of Science ®Google Scholar
• Mocroft A, Reiss P, Gasiorowski J, et al. Serious fatal and non fatal non AIDS defining illnesses in Europe. J Acquir Immune Defic Syndr. 2010;55(2):262–270. PMid: 20700060. doi:10.1097/QAI.0b013e3181e9be6b
   PubMed Web of Science ®Google Scholar
• Bibas M, Biava G, Antinori A. HIV-associated venous thromboembolism. Mediterr J Hematol Infect Dis. 2011;3:e2011030. doi:10.4084/mjhid.2011.030
   PubMedGoogle Scholar
• Jenkins RE, Peters BS, Pinching AJ. Thromboembolic disease in AIDS is associated with cytomegalovirus disease. AIDS. 1991;5(12):1540–1542. PMid: 1667576. doi:10.1097/00002030-199112000-00025
   PubMed Web of Science ®Google Scholar
• Laing RBS, Brettle RP, Leen CLS. Venous thrombosis in HIV infection. Int J STD AIDS. 1996; (2):82–85. PMid: 19244539. doi:10.1258/0956462961917410
   PubMed Web of Science ®Google Scholar
• Howling SJ, Shaw PJ, Miller RF. Acute pulmonary embolism in patients with HIV disease. Sex Transm Infect. 1999;75(1):25–29. PMid:10448338 PMCid: 1758180. doi:10.1136/sti.75.1.25
   PubMed Web of Science ®Google Scholar
• George SL, Swindells S, Knudson R, Stapleton JT. Unexplained Thrombosis in HIV-infected Patients Receiving Protease Inhibitors: report of Seven Cases. Am J Med. 1999;107(6):624–626. doi:10.1016/S0002-9343(99)00296-X
   PubMed Web of Science ®Google Scholar
• Sullivan PS, Dworkin MS, Jones JL, Hooper WG. Epidemiology of thrombosis in HIV-infected individuals. AIDS. 2000;14:321. PMid: 10716509. doi:10.1097/00002030-200002180-00015
   PubMed Web of Science ®Google Scholar
• Saber AA, Aboolian A, LaRaja RD, Baron H, Manna K. HIV/AIDS and the risk of deep vein thrombosis a study of 45 patients with lower extremity involvement. Am Surg. 2001;67:645–647. PMid: 11450780.
   PubMed Web of Science ®Google Scholar
• Goldhaber SZ. Risk Factors for Thromboembolism. JACC. 2010;29:1–7. PMid: 20620709. doi:10.1016/j.jacc.2010.01.057
   Google Scholar
• Jacobson MC, Debuze BJ, Aboulafia DM. Thrombotic complications in patients infected with HIV in the era of Highly active antiretroviral therapy: a case series. Clin Infect Dis. 2004;39:1214–1222. PMid: 15486847. doi:10.1086/424664
   PubMed Web of Science ®Google Scholar
• Neuhaus J, Jacobs DR, Baker JV, et al. Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infection. J Infect Dis. 2010;201:1788–1795. doi:10.1086/652749
   PubMed Web of Science ®Google Scholar
• Bernasconi E, Uhr M, Magenta L, Ranno A, Telenti A. Homocysteinemia in HIV-infected patients treated with highly active antiretroviral therapy. AIDS. 2001;15:1081–1082. PMid: 11400001. doi:10.1097/00002030-200105250-00027
   PubMed Web of Science ®Google Scholar
• Guaraldi G, Ventura P, Garlassi E, et al. Hyperhomocysteinemia inHIV-infected patients: determinants of variability and correlations with predictors of cardiovascular disease. HIV Med. 2009;10:28–34. PMid: 19125962. doi:10.1111/j.1468-1293.2008.00649.x
   PubMed Web of Science ®Google Scholar
• Feffer SE, Fox RL, Orsen MM, Harjai KJ, Glatt AE. Thrombotic tendencies and correlation with clinical status in patients infected with HIV. South Med J. 1995;88(11):1126–1130. PMid: 7481983. doi:10.1097/00007611-199511000-00008
   PubMed Web of Science ®Google Scholar
• Klein SK, Slim EJ, de Kruif MD, et al. Is chronic HIV infection associated with venous thrombotic disease? A systematic review. Neth J Med. 2005;63:129–136. PMid: 15869040.
   PubMed Web of Science ®Google Scholar
• Karpatkin S, Nardi M, Green D. Platelet and coagulation defects associated with HIV-1-infection. Thromb Haemost. 2002;88:389–401. PMid: 12353066. doi:10.1055/s-0037-1613228
   PubMed Web of Science ®Google Scholar
• Saif MW, Bona R, Greenberg B. AIDS and thrombosis: retrospective study of 131 HIV-infected patients. AIDS Patient Care STDS. 2001;15(6):311–320. PMid: 11445013. doi:10.1089/108729101750279687
   PubMed Web of Science ®Google Scholar
• Crum-Cianflone NF, Weekes J, Bavaro M. Thromboses among HIV-infected patients during the highly active antiretroviral therapy era. AIDS Patient Care STDS. 2008;22(10):771–778. PMid:18783326 PMCid: 2753452. doi:10.1089/apc.2008.0010
   PubMed Web of Science ®Google Scholar
• Lijfering WM, Sprenger HG, Son van WJ. Mesenteric vein thrombosis associated with primary cytomegalovirus infection: a case report. Blood Coagul Fibrinolysis. 2007;18:509–511. doi:10.1097/MBC.0b013e3281a3bef9
   PubMed Web of Science ®Google Scholar
• Abgueguen P, Delbos V, Ducancelle A, Jomaa S, Fanello S, Pichard E. Venous thrombosis in immunocompetent patients with acute cytomegalovirus infection: a complication that may be underestimated. Clin Microbiol Infect. 2010;16:851–854. PMid: 19686279. doi:10.1111/j.1469-0691.2009.03022.x
   PubMed Web of Science ®Google Scholar
• Tichelaar VY, Sprenger HG, Mäkelburg AB, Niesters BGM, Kluin-Nelemans HC, Lijfering WM. Active cytomegalovirus infection in patients with acute venous thrombosis: a case-control study. Am J Hematol. 2011;86(6):510–512. PMid: 21509792. doi:10.1002/ajh.22006
   PubMed Web of Science ®Google Scholar
• Justo D, Finn T, Atzmony L, Guy N, Steinvil A. Thrombosis associated with acute cytomegalovirus infection: a meta-analysis. Eur J Intern Med. 2011;22(2):195–199. Epub 2010 Dec 16. doi:10.1016/j.ejim.2010.11.006
   PubMed Web of Science ®Google Scholar
• Atzmony L, Halutz O, Avidor B, et al. Incidence of cytomegalovirus- associated thrombosis and its risk factors: a case-control study. Thromb Res. 2010;126(6):e439–43. doi:10.1016/j.thromres.2010.09.006
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Guidelines for prevention and treatment of opportunistic infections in HIV infected adults and adolescents. MMWR Recomm Rep. 2009;58(RR–4):1–207. PMCid: 2821196.
   Google Scholar
• Mulder R, Tichelaar YI, Sprenger HG, et al. Relationship between cytomegalovirus infection and procoagulant changes in human immunodeficiency virus-infected patients. Clin Microbiol Infect. 2011;17(5):747–749. doi:10.1111/j.1469-0691.2010.03415.x
   PubMed Web of Science ®Google Scholar
• Santiago MB, Cossermelli W, Tuma MF, et al. Anticardiolipin antibodies in patients with infectious diseases. Clin Rheumat. 1989;8:23–28. doi:10.1007/BF02031064
   PubMed Web of Science ®Google Scholar
• Sule AA, Pandit N, Handa P, et al. Risk of venous thromboembolism in patients infected with HIV: a cohort study. Int J Angiol. 2013;22:95–100. doi:10.1055/s-0033-1333866
   PubMedGoogle Scholar
• World Health Organization. Global Tuberculosis Report 2019. Geneva, Switzerland: World Health Organization; 2019.
   Google Scholar
• Tornheim JA, Dooley KE. Tuberculosis associated with HIV infection. Microbiol Spectr. 2017;1:5.
   Google Scholar
• Engels EA, Biggar RJ, Hall HI, et al. Cancer risk in people infected with human immunodeficiency virus in the United States. Int J Cancer. 2008;123(1):187–194. PMid: 18435450. doi:10.1002/ijc.23487
   PubMed Web of Science ®Google Scholar
• Schneider E, Whitmore S, Glynn KM, Dominguez K, Mitsch A, McKenna MT. Revised surveillance case definitions for HIV infection among adults, adolescents, and children aged <18 months and for HIV infection and AIDS among children aged 18 months to <13 years-United States, 2008. MMWR Recomm Rep. 2008;57(RR–10):1–12.
   PubMedGoogle Scholar
• Majluf-Cruz A, Silva-Estrada M, Sánchez-Barboza R, et al. Venous Thrombosis among patients with AIDS. Clin Appl Thromb Hemost. 2004;10(1):19–25. PMid: 14979401. doi:10.1177/107602960401000104
   PubMed Web of Science ®Google Scholar
• Lijfering WM, Ten Kate MK, Sprenger HG, Van der Meer J. Absolute risk of venous and arterial thrombosis in HIV-infected patients and effects of combination antiretroviral therapy. J Thromb Haemost. 2006;4:1928–1930. PMid: 16961600. doi:10.1111/j.1538-7836.2006.02047.x
   PubMed Web of Science ®Google Scholar
• George SL, Swindells S, Knudson R. Unexplained thrombosis in HIV-infected patients receiving pro- tease inhibitors: report of seven cases. Am J Med. 1999;107:624–626. doi:10.1016/S0002-9343(99)00296-X
   PubMed Web of Science ®Google Scholar
• Holbrook AM, Pereira JA, Labiris R, et al. Systematic overview of warfarin and its drug and food interactions. Arch Intern Med. 2005;165:1095–1106. PMid: 15911722. doi:10.1001/archinte.165.10.1095
   PubMed Web of Science ®Google Scholar